Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
34,100
Employees34,100
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
34,100
Employees34,100

BMY Key Statistics

Market cap
97.38B
Market cap97.38B
Price-Earnings ratio
17.63
Price-Earnings ratio17.63
Dividend yield
5.19%
Dividend yield5.19%
Average volume
14.14M
Average volume14.14M
High today
$47.88
High today$47.88
Low today
$46.85
Low today$46.85
Open price
$46.99
Open price$46.99
Volume
10.49M
Volume10.49M
52 Week high
$63.33
52 Week high$63.33
52 Week low
$39.35
52 Week low$39.35

BMY News

Simply Wall St 6d
Bristol-Myers Squibb Showcases Breakthrough Oncology Data at ASCO 2025 Meeting

is advancing in oncology, as evidenced by its upcoming presentations at the 2025 ASCO Annual Meeting, which highlight its strong focus on cancer treatments. Thi...

Bristol-Myers Squibb Showcases Breakthrough Oncology Data at ASCO 2025 Meeting

Analyst ratings

71%

of 28 ratings
Buy
25%
Hold
71.4%
Sell
3.6%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.